Literature DB >> 9034998

Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.

M D Smith1, S Triantafillou, A Parker, P P Youssef, M Coleman.   

Abstract

OBJECTIVE: To establish the presence of inflammation in and cytokine production by synovial membranes from patients with various stages of early osteoarthritis (OA), with knee pain, normal knee radiographs, and arthroscopic evidence of chondral damage.
METHODS: Synovial membrane samples were obtained from the knees of 63 patients at the time of arthroscopy for unexplained knee pain or at the time of joint replacement surgery. Evaluations of synovial membrane variables including thickness of lining layer, vascularity, and inflammatory cell infiltrate were by a blinded observer. In a subset of 20 patients, production of interleukin 1 alpha (IL-1 alpha), interleukin 1 beta (IL-1 beta), tumor necrosis factor alpha (TNF-alpha), and IL-1 receptor antagonist (IL-1ra) at the mRNA and protein levels was determined using in situ hybridization with biotin labeled ribo-probes and immunohistochemistry.
RESULTS: There was evidence of thickening of the lining layer, increased vascularity, and inflammatory cell infiltration in synovial membranes from patients with all grades of OA, with the most marked changes seen in synovial tissue from patients with advanced grades of OA. Similarly, production of IL-1 alpha, IL-1 beta, and TNF-alpha was present in synovial membranes from all patients with OA, irrespective of the degree of articular cartilage damage. There was a trend to decreased levels of IL-1ra in synovial membranes from patients with OA that did not attain statistical significance. Similarly, there was a decrease in the ratio of IL-1ra to IL-1 alpha and beta with increasing grades of OA.
CONCLUSION: Chronic inflammatory changes with production of proinflammatory cytokines are a feature of synovial membranes from patients with early OA, with the most severe changes seen in patients at the time of joint replacement surgery resembling those seen in rheumatoid arthritis. This low grade synovitis results in the production of cytokines that may contribute to the pathogenesis of OA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034998

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  164 in total

Review 1.  The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.

Authors:  Jérémie Sellam; Francis Berenbaum
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

2.  Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice.

Authors:  Ru Liu-Bryan; Robert Terkeltaub
Journal:  Arthritis Rheum       Date:  2010-07

Review 3.  Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis.

Authors:  Paul I Mapp; David A Walsh
Journal:  Nat Rev Rheumatol       Date:  2012-05-29       Impact factor: 20.543

4.  Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi.

Authors:  J L Kamm; A J Nixon; T H Witte
Journal:  Equine Vet J       Date:  2010-09-14       Impact factor: 2.888

Review 5.  Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?

Authors:  M D Smith; D Baeten; A-K Ulfgren; I B McInnes; O Fitzgerald; B Bresnihan; P P Tak; D Veale
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

6.  Telomerase transduced osteoarthritis fibroblast-like synoviocytes display a distinct gene expression profile.

Authors:  Yubo Sun; David R Mauerhan; Gary S Firestein; Bryan J Loeffler; Edward N Hanley; Helen E Gruber
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

7.  scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy.

Authors:  L R Goodrich; J C Grieger; J N Phillips; N Khan; S J Gray; C W McIlwraith; R J Samulski
Journal:  Gene Ther       Date:  2015-04-23       Impact factor: 5.250

Review 8.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

9.  Effects of (-)-epigallocatechin-3-gallate on cyclooxygenase 2, PGE(2), and IL-8 expression induced by IL-1beta in human synovial fibroblasts.

Authors:  Guo-Shu Huang; Ching-Ya Tseng; Chian-Her Lee; Sui-Long Su; Herng-Sheng Lee
Journal:  Rheumatol Int       Date:  2009-09-24       Impact factor: 2.631

10.  Early lymphocyte activation in the synovial microenvironment in patients with osteoarthritis: comparison with rheumatoid arthritis patients and healthy controls.

Authors:  R Rollín; F Marco; J A Jover; J A García-Asenjo; L Rodríguez; L López-Durán; B Fernández-Gutiérrez
Journal:  Rheumatol Int       Date:  2008-01-18       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.